ArticleRSC advances2026
Biochar loading modulates pore accessibility and CO
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MIL-100(Al)/MIL-110(Al)-biochar materials were prepared by solvothermal crystallization of aluminum trimesate phases in the presence of activated bamboo-derived biochar. BC-10 and BC-20 denote nominal precursor-basis biochar additions of 10 and 20 wt%, respectively, rather than measured final composite mass fractions. PXRD reflections assigned to MIL-100(Al) and MIL-110(Al) were retained after biochar addition. Conventional TEM revealed coexisting rod-like and faceted/polyhedral particle habits in BC-0 and their spatial association with irregular carbonaceous domains in BC-10. However, peak overlap and the absence of quantitative phase analysis in HRTEM preclude determination of phase fractions or lattice-level interfaces. Among the three investigated formulations, BC-10 gave the highest equilibrium CO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.